Contribution of meta-analyses to the evaluation of treatments for advanced colorectal cancer
- 1 August 2002
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 2 (4) , 417-425
- https://doi.org/10.1586/14737140.2.4.417
Abstract
In the last decade, the Meta-Analysis Group in Cancer (formerly Advanced Colorectal Cancer Meta-Analysis Project) has systematically used a meta-analytic to reassess the efficacy and toxicity of various fluoropyrimidine regimens in advanced colorectal cancer, as well as to investigate related questions, such as the relation between tumor response and survival. In this paper, the basic methodology of meta-analysis is reviewed and the findings of seven successive meta-analyses conducted between 1989-2000 by the Meta-Analysis Group in Cancer are summarized. The interested reader can refer to the statistical appendix for details on the methodology used for all meta-analyses.Keywords
This publication has 10 references indexed in Scilit:
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- Overcoming the limitations of current meta-analysis of randomised controlled trialsThe Lancet, 1998
- Meta-analysis of Randomized Controlled TrialsJAMA, 1995
- A general parametric approach to the meta‐analysis of randomized clinical trialsStatistics in Medicine, 1991
- Considerations for the meta-analysis of randomized clinical trialsControlled Clinical Trials, 1989
- Adjuvant Therapy of Colorectal CancerPublished by American Medical Association (AMA) ,1988
- Avoidance of large biases and large random errors in the assessment of moderate treatment effects: The need for systematic overviewsStatistics in Medicine, 1987
- Regional chemotherapy of neoplastic diseasesPharmacology & Therapeutics, 1983
- Reporting results of cancer treatmentCancer, 1981
- The Combination of Estimates from Different ExperimentsPublished by JSTOR ,1954